Highlights

[PHARMA] QoQ Quarter Result on 2014-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 14-May-2014
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2014
Quarter 31-Mar-2014  [#1]
Profit Trend QoQ -     25.96%    YoY -     5.84%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Revenue 627,103 502,086 525,072 468,672 567,860 440,807 437,633 27.02%
  QoQ % 24.90% -4.38% 12.03% -17.47% 28.82% 0.73% -
  Horiz. % 143.29% 114.73% 119.98% 107.09% 129.76% 100.73% 100.00%
PBT 37,854 24,945 24,622 38,159 33,007 13,461 9,605 148.88%
  QoQ % 51.75% 1.31% -35.48% 15.61% 145.20% 40.15% -
  Horiz. % 394.11% 259.71% 256.35% 397.28% 343.64% 140.15% 100.00%
Tax -1,233 -9,944 -8,665 -11,513 -11,740 -9,291 -3,434 -49.39%
  QoQ % 87.60% -14.76% 24.74% 1.93% -26.36% -170.56% -
  Horiz. % 35.91% 289.57% 252.33% 335.26% 341.88% 270.56% 100.00%
NP 36,621 15,001 15,957 26,646 21,267 4,170 6,171 226.72%
  QoQ % 144.12% -5.99% -40.11% 25.29% 410.00% -32.43% -
  Horiz. % 593.44% 243.09% 258.58% 431.79% 344.63% 67.57% 100.00%
NP to SH 36,697 14,955 15,975 26,217 20,813 3,751 5,865 238.42%
  QoQ % 145.38% -6.38% -39.07% 25.96% 454.87% -36.04% -
  Horiz. % 625.69% 254.99% 272.38% 447.01% 354.87% 63.96% 100.00%
Tax Rate 3.26 % 39.86 % 35.19 % 30.17 % 35.57 % 69.02 % 35.75 % -79.65%
  QoQ % -91.82% 13.27% 16.64% -15.18% -48.46% 93.06% -
  Horiz. % 9.12% 111.50% 98.43% 84.39% 99.50% 193.06% 100.00%
Total Cost 590,482 487,085 509,115 442,026 546,593 436,637 431,462 23.20%
  QoQ % 21.23% -4.33% 15.18% -19.13% 25.18% 1.20% -
  Horiz. % 136.86% 112.89% 118.00% 102.45% 126.68% 101.20% 100.00%
Net Worth 525,351 507,124 502,293 515,022 486,672 473,402 480,568 6.10%
  QoQ % 3.59% 0.96% -2.47% 5.83% 2.80% -1.49% -
  Horiz. % 109.32% 105.53% 104.52% 107.17% 101.27% 98.51% 100.00%
Dividend
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Div 31,055 20,698 10,356 10,352 16,049 7,760 8,810 131.08%
  QoQ % 50.03% 99.86% 0.04% -35.50% 106.81% -11.91% -
  Horiz. % 352.48% 234.94% 117.55% 117.50% 182.17% 88.09% 100.00%
Div Payout % 84.63 % 138.41 % 64.83 % 39.49 % 77.11 % 206.90 % 150.22 % -31.72%
  QoQ % -38.86% 113.50% 64.17% -48.79% -62.73% 37.73% -
  Horiz. % 56.34% 92.14% 43.16% 26.29% 51.33% 137.73% 100.00%
Equity
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Net Worth 525,351 507,124 502,293 515,022 486,672 473,402 480,568 6.10%
  QoQ % 3.59% 0.96% -2.47% 5.83% 2.80% -1.49% -
  Horiz. % 109.32% 105.53% 104.52% 107.17% 101.27% 98.51% 100.00%
NOSH 258,794 258,737 258,914 258,805 258,868 258,689 258,370 0.11%
  QoQ % 0.02% -0.07% 0.04% -0.02% 0.07% 0.12% -
  Horiz. % 100.16% 100.14% 100.21% 100.17% 100.19% 100.12% 100.00%
Ratio Analysis
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
NP Margin 5.84 % 2.99 % 3.04 % 5.69 % 3.75 % 0.95 % 1.41 % 157.24%
  QoQ % 95.32% -1.64% -46.57% 51.73% 294.74% -32.62% -
  Horiz. % 414.18% 212.06% 215.60% 403.55% 265.96% 67.38% 100.00%
ROE 6.99 % 2.95 % 3.18 % 5.09 % 4.28 % 0.79 % 1.22 % 219.18%
  QoQ % 136.95% -7.23% -37.52% 18.93% 441.77% -35.25% -
  Horiz. % 572.95% 241.80% 260.66% 417.21% 350.82% 64.75% 100.00%
Per Share
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 242.32 194.05 202.80 181.09 219.36 170.40 169.38 26.88%
  QoQ % 24.88% -4.31% 11.99% -17.45% 28.73% 0.60% -
  Horiz. % 143.06% 114.56% 119.73% 106.91% 129.51% 100.60% 100.00%
EPS 14.18 5.78 6.17 10.13 8.04 1.45 2.27 238.05%
  QoQ % 145.33% -6.32% -39.09% 26.00% 454.48% -36.12% -
  Horiz. % 624.67% 254.63% 271.81% 446.26% 354.19% 63.88% 100.00%
DPS 12.00 8.00 4.00 4.00 6.20 3.00 3.41 130.83%
  QoQ % 50.00% 100.00% 0.00% -35.48% 106.67% -12.02% -
  Horiz. % 351.91% 234.60% 117.30% 117.30% 181.82% 87.98% 100.00%
NAPS 2.0300 1.9600 1.9400 1.9900 1.8800 1.8300 1.8600 5.99%
  QoQ % 3.57% 1.03% -2.51% 5.85% 2.73% -1.61% -
  Horiz. % 109.14% 105.38% 104.30% 106.99% 101.08% 98.39% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
RPS 240.06 192.20 201.00 179.41 217.38 168.74 167.53 27.02%
  QoQ % 24.90% -4.38% 12.03% -17.47% 28.83% 0.72% -
  Horiz. % 143.29% 114.73% 119.98% 107.09% 129.76% 100.72% 100.00%
EPS 14.05 5.72 6.12 10.04 7.97 1.44 2.25 237.97%
  QoQ % 145.63% -6.54% -39.04% 25.97% 453.47% -36.00% -
  Horiz. % 624.44% 254.22% 272.00% 446.22% 354.22% 64.00% 100.00%
DPS 11.89 7.92 3.96 3.96 6.14 2.97 3.37 131.23%
  QoQ % 50.13% 100.00% 0.00% -35.50% 106.73% -11.87% -
  Horiz. % 352.82% 235.01% 117.51% 117.51% 182.20% 88.13% 100.00%
NAPS 2.0111 1.9413 1.9228 1.9715 1.8630 1.8122 1.8396 6.11%
  QoQ % 3.60% 0.96% -2.47% 5.82% 2.80% -1.49% -
  Horiz. % 109.32% 105.53% 104.52% 107.17% 101.27% 98.51% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 -
Price 4.5800 4.6300 4.6100 4.4600 4.4500 4.8200 4.4900 -
P/RPS 1.89 2.39 2.27 2.46 2.03 2.83 2.65 -20.12%
  QoQ % -20.92% 5.29% -7.72% 21.18% -28.27% 6.79% -
  Horiz. % 71.32% 90.19% 85.66% 92.83% 76.60% 106.79% 100.00%
P/EPS 32.30 80.10 74.72 44.03 55.35 332.41 197.80 -70.03%
  QoQ % -59.68% 7.20% 69.70% -20.45% -83.35% 68.05% -
  Horiz. % 16.33% 40.50% 37.78% 22.26% 27.98% 168.05% 100.00%
EY 3.10 1.25 1.34 2.27 1.81 0.30 0.51 231.97%
  QoQ % 148.00% -6.72% -40.97% 25.41% 503.33% -41.18% -
  Horiz. % 607.84% 245.10% 262.75% 445.10% 354.90% 58.82% 100.00%
DY 2.62 1.73 0.87 0.90 1.39 0.62 0.76 127.69%
  QoQ % 51.45% 98.85% -3.33% -35.25% 124.19% -18.42% -
  Horiz. % 344.74% 227.63% 114.47% 118.42% 182.89% 81.58% 100.00%
P/NAPS 2.26 2.36 2.38 2.24 2.37 2.63 2.41 -4.18%
  QoQ % -4.24% -0.84% 6.25% -5.49% -9.89% 9.13% -
  Horiz. % 93.78% 97.93% 98.76% 92.95% 98.34% 109.13% 100.00%
Price Multiplier on Announcement Date
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Date 23/02/15 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 -
Price 5.2800 4.4500 4.6200 4.7000 4.2900 4.7200 4.6600 -
P/RPS 2.18 2.29 2.28 2.60 1.96 2.77 2.75 -14.31%
  QoQ % -4.80% 0.44% -12.31% 32.65% -29.24% 0.73% -
  Horiz. % 79.27% 83.27% 82.91% 94.55% 71.27% 100.73% 100.00%
P/EPS 37.24 76.99 74.88 46.40 53.36 325.52 205.29 -67.86%
  QoQ % -51.63% 2.82% 61.38% -13.04% -83.61% 58.57% -
  Horiz. % 18.14% 37.50% 36.48% 22.60% 25.99% 158.57% 100.00%
EY 2.69 1.30 1.34 2.16 1.87 0.31 0.49 210.23%
  QoQ % 106.92% -2.99% -37.96% 15.51% 503.23% -36.73% -
  Horiz. % 548.98% 265.31% 273.47% 440.82% 381.63% 63.27% 100.00%
DY 2.27 1.80 0.87 0.85 1.45 0.64 0.73 112.60%
  QoQ % 26.11% 106.90% 2.35% -41.38% 126.56% -12.33% -
  Horiz. % 310.96% 246.58% 119.18% 116.44% 198.63% 87.67% 100.00%
P/NAPS 2.60 2.27 2.38 2.36 2.28 2.58 2.51 2.37%
  QoQ % 14.54% -4.62% 0.85% 3.51% -11.63% 2.79% -
  Horiz. % 103.59% 90.44% 94.82% 94.02% 90.84% 102.79% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS